首页> 外国专利> Humanized monoclonal antibody fragment Fab or Fab fragment comprising the, and their use for the manufacture of a Medicament polypeptide Glucagon Receptor Antagonist for the Treatment or prevention of diabetes type 1 or 2

Humanized monoclonal antibody fragment Fab or Fab fragment comprising the, and their use for the manufacture of a Medicament polypeptide Glucagon Receptor Antagonist for the Treatment or prevention of diabetes type 1 or 2

机译:人源化单克隆抗体片段Fab或包含其的Fab片段,及其在制备用于治疗或预防1型或2型糖尿病的药物多肽胰高血糖素受体拮抗剂中的用途

摘要

Humanized monoclonal antibody fragment Fab or Fab fragment that includes, where the Fab fragment is able to bind to the receptors of Rat and murine human glucagon, glucagon and inhibit the binding to each Receptor with a Ki of less than 50nm, Recep polypeptide Antagonists Tor which inhibited the glucagon Hormone glucagon Binding to its receptor.Vector comprising a Nucleic Acid Sequence encoding said or Humanized monoclonal antibody Fab fragment and host Cell comprising a sequence of heterologous polynucleotide encoding said or Humanized monoclonal antibody Fab Fragment.Pharmaceutical composition containing same and their use for the manufacture of a Medicament useful for the Treatment or prevention of diabetes type 1 or type 2 or for Achieving weight loss in a Human.
机译:人源化单克隆抗体片段Fab或Fab片段,包括其中Fab片段能够结合大鼠和鼠类人胰高血糖素的受体,胰高血糖素并以小于50nm的Ki抑制与每个受体的结合的Recep多肽拮抗剂Tor抑制胰高血糖素激素激素胰高血糖素与其受体的结合。包含编码所述或人源化单克隆抗体Fab片段的核酸序列的载体和包含编码所述或人源化单克隆抗体Fab片段的异源多核苷酸序列的宿主细胞。包含其的药物组合物及其用途制造可用于治疗或预防1型或2型糖尿病或减轻人的体重的药物。

著录项

  • 公开/公告号AR070844A1

    专利类型

  • 公开/公告日2010-05-05

    原文格式PDF

  • 申请/专利权人 ELI LILLY AND COMPANY;

    申请/专利号AR2009P100889

  • 发明设计人

    申请日2009-03-12

  • 分类号C07K16/26;C12N15/13;C12N15/63;A61K39/395;A61P3/10;

  • 国家 AR

  • 入库时间 2022-08-21 18:47:32

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号